Présentation de l'entreprise
We are focused on building a Global Specialty Pharmaceutical company to be proud of. We are engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets.
By embracing innovation we have been able to develop a cutting edge pipeline of products to meet the needs of both patients suffering from diseases for which no effective treatments are available, and their families and healthcare professionals.
This approach makes a real difference to patients and their families, helping to bring both relief and hope.
The business specialises in the core fields of oncology, nephrology, immunology / allergy and the central nervous system. We are developing leading-edge biotechnologies by concentrating on the use of antibodies to create and discover new drugs. We are currently focussed on launching pipeline products originated by Kyowa Kirin in Europe and the United States.
To grow we need the best people. People who are passionate about making a real difference and never settle for the status quo. People with a passion for innovation and science.
Although an international operation, we are dedicated to keeping the family feel to our business and to continuing to build our reputation as a company that cares about its people.
We treat everyone as an individual. We have an environment and culture that inspires and challenges everyone to think creatively and work together to create a better world and help individuals live healthier, more fulfilling lives.
We are a business that believes in transparency, fairness and compliance. As we expand, we need team members that live by our values, work collaboratively and are motivated to make a positive impact on the lives of patients. Team members who are prepared to devote themselves to saving the lives of those suffering from diseases through the development of new drugs and belief in our ‘Commitment to Life’ mission statement.
We believe that we are a special company to work for. We hope you will too.